Ivancovsky-Wajcman, D, Villota-Rivas, M, Manolas, M, Villas-Riotorto, V, Arora, A, Brennan, PN, Mauricio, D, Leith, D, Willemse, J, Betel, M, Alnaser, F, El Kassas, M, Lazarus, J. Healthcare provider perspectives on mental health in metabolic dysfunction-associated steatotic liver disease and steatohepatitis: the role of multidisciplinary teams and sex differences. JOURNAL OF HEPATOLOGY. 2026; 84DOI:. PMID:. IF:33.000(Q1/1D).

Ivancovsky-Wajcman, D, Villota-Rivas, M, Manolas, M, Villas-Riotorto, V, Arora, A, Brennan, PN, Mauricio, D, Leith, D, Willemse, J, Betel, M, Alnaser, F, El Kassas, M, Lazarus, J. Factors influencing mental health care provision for people with metabolic dysfunction-associated steatotic liver disease and steatohepatitis. JOURNAL OF HEPATOLOGY. 2026; 84DOI:. PMID:. IF:33.000(Q1/1D).

Romero-Gómez, M, Escalada, J, Noguerol, M, Pérez, A, Carretero, J, Crespo, J, Mascort, JJ, Aguilar, I, Tinahones, F, Cañones, P, Gómez-Huelgas, R, de Luis, D, Trullos, IG, Aller, R, Rubio, MA, Calleja, JL. Multidisciplinary clinical practice guidelines for the management of metabolic fatty liver disease. Gastroenterologia y Hepatologia. 2026; 49(5)DOI:10.1016/j.gastrohep.2025.502640. PMID:. IF:1.900(Q3/7D).

Diamantopoulos, L, Kalligeros, M, Isaacs, SD, Mauricio, D. Association of Metabolic Dysfunction-Associated Steatohepatitis with Metabolic-Related Diseases Diabetes, Prediabetes, and Obesity. Clinics in Liver Disease. 2026; 30(2)DOI:10.1016/j.cld.2025.12.001. PMID:42142893. IF:4.100(Q1/3D).